ketanserin has been researched along with Obsessive-Compulsive Disorder in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, KH | 1 |
Hansen, ES | 1 |
Pinborg, LH | 1 |
Hasselbalch, SG | 1 |
Svarer, C | 1 |
Holm, S | 1 |
Bolwig, TG | 1 |
Knudsen, GM | 1 |
1 trial available for ketanserin and Obsessive-Compulsive Disorder
Article | Year |
---|---|
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain Mapping; Caudate Nucleus; Female; Fluorine Rad | 2005 |